AI is revolutionizing drug and therapeutics discovery, but the supervised learning approaches that have dominated up to now — which depend on data labeled by human experts — aren’t scalable. Noetik is generating the hundreds of terabytes of genomic, transcriptomic, and proteomic data on cells and tissues that will be needed to power self-supervised, transformer-based predictive modeling in the realm of cancer immunotherapy. The company’s platform helps identify novel targets for therapeutics and predicts how patients will respond.
In The Media
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Advancing precision medicine by combining the efficacy of antibodies with the binding ability of small molecules
Using synthetic biology to manufacture carbon-negative materials